MedTrace Logo

Transcutaneous Bilirubinometry in Neonates With the Bilicare System

NCT02445755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2015-06-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the performance of a new transcutaneous ("measured through skin") bilirubin device (BiliCare™) to measure bilirubin levels. The investigators plan to evaluate the clinical performance of this device as a point of care test. If the investigators can validate the BiliCare™ with bilirubin from your baby's blood they could verify a non-invasive alternative for measuring bilirubin.

Conditions

  • Transcutaneous Bilirubinometry

Sponsors & Collaborators

Eligibility

Min Age
35 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445755 on ClinicalTrials.gov